课题基金 / 基金详情

ETHANOL TOLERANCE AND DEPENDENCE IN VITRO

ETHANOL TOLERANCE AND DEPENDENCE IN VITRO
体外乙醇耐受性和依赖性
批准号:
3108909
负责人:
ELLIOTT RICHELSON
金额:
$11.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1980
资助国家:
美国
项目状态:
已结题
起止时间:
1980-04-01 至 1986-03-31

项目摘要

项目成果

ELLIOTT RICHELSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The overall objectives of the proposed research are to determine the acute and chronic effects of ethanol on neurotransmitter receptor function and on membrane fluidity. A clone of mouse neuroblastoma (N1E-115) which contains prostaglandin and muscarinic acetylcholine receptors and a clone of rat glioma (C-6) which contains Beta-adrenergic receptor will be used in these studies. These receptors will be assayed by pharmacological and radioligand binding techniques. Receptor-mediated cyclic AMP (prostaglandin, Beta-adrenergic receptors) and cyclic GMP (muscarinic receptor) synthesis will be used to pharmacologically study these receptors while (3H)prostaglandin E1, (3H)quinuclidinylbenzilate, and (125I)iodohydroxybenzylpindolol binding will be used for direct assay of the prostaglandin, muscarinic acetylcholine and Beta-adrenergic receptors, respectively. Our preliminary experiments showed an effect of ethanol on the function of prostaglandin and muscarinic acetylcholine receptors. In addition, after several days of exposure to ethanol, there developed a cellular tolerance to the effects of ethanol on these receptors. Some of our data may be explained by changes in membrane fluidity caused by ethanol as reported by others. Thus, fluorescence polarization techniques will be used to obtain direct evidence for an effect of ethanol on membrane fluidity of these cultured cells. The role of membrane fluidity changes in the acute and chronic effects of ethanol on neurotransmitter receptor function and in the induction of cellular tolerance to ethanol may be elucidated from these studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NT69L: a potential, novel antischizophrenic drug
  • 批准号:
    7595117
  • 项目类别:
  • 资助金额:
    $28.23万
  • 财政年份:
    2006
  • 负责人:
    ELLIOTT RICHELSON
  • 依托单位:
NT69L: a potential, novel antischizophrenic drug
  • 批准号:
    7093854
  • 项目类别:
  • 资助金额:
    $28.27万
  • 财政年份:
    2006
  • 负责人:
    ELLIOTT RICHELSON
  • 依托单位:
NT69L: a potential, novel antischizophrenic drug
  • 批准号:
    7409750
  • 项目类别:
  • 资助金额:
    $28.23万
  • 财政年份:
    2006
  • 负责人:
    ELLIOTT RICHELSON
  • 依托单位:
NT69L: a potential, novel antischizophrenic drug
  • 批准号:
    7676559
  • 项目类别:
  • 资助金额:
    $11.42万
  • 财政年份:
    2006
  • 负责人:
    ELLIOTT RICHELSON
  • 依托单位:
国内基金
海外基金
Calcium/NFAT/GLUT3通路调控糖酵解代谢在CAR-T细胞耗竭中的作用和机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    张明明
  • 依托单位:
miR-30调控Calcium/Calcineurin通路在慢性肾脏病心肌保护中的作用
  • 批准号:
    81670699
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    郑春霞
  • 依托单位:
水稻OsCAS(Calcium-sensing Receptor)基因的功能分析
  • 批准号:
    30900771
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2009
  • 负责人:
    赵昕
  • 依托单位: